Axiom Investment Management’s Sana Biotechnology SANA Stock Holding History

Axiom Investment Management’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$70	Buy	+20	New	+$64	﹤0.01%	514

Other funds holding SANA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Swiss National Bank Zurich, Switzerland $191B AUM 45.21% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Axiom Investment Management's SANA Position: Q2 2026 in Review

Axiom Investment Management opened a new position in Sana Biotechnology (SANA) in Q2 2026: 20 shares worth $70. The stake represents ﹤0.01% of the portfolio and ranks #514 among its holdings.

101 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

Axiom Investment Management held 20 shares of Sana Biotechnology worth $70 as of Q2 2026.
Sana Biotechnology was a new Axiom Investment Management position in Q2 2026.
Sana Biotechnology made up ﹤0.01% of Axiom Investment Management's portfolio in Q2 2026, its #514 holding.
101 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Axiom Investment Management's 13F filing for Q2 2026, filed 31 Jul 2026.